Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
R&D Expenses
$261.10M
TTM · Period ending: · USD

BIO R&D Expenses
Latest reported$261.10Mperiod ending
Latest reported$261.10Mperiod ending
BIO TTM R&D Expenses ($0.00 → $261.10M)
TTM R&D Expenses
High-resolution chart · PNG
BIO r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 69,018,000 | |
| 68,697,000 | |
| 68,140,000 | |
| 70,423,000 | |
| 65,051,000 | |
| 58,571,000 | |
| 51,200,000 | |
| 43,000,000 | |
| 42,200,000 | |
| 41,900,000 | |
| 41,300,000 | |
| 43,800,000 | |
| 44,600,000 | |
| 45,200,000 | |
| 46,100,000 | |
| 43,600,000 | |
| 42,300,000 | |
| 40,700,000 | |
| 39,500,000 | |
| 38,200,000 | |
| 37,000,000 | |
| 35,900,000 | |
| 34,700,000 | |
| 33,700,000 | |
| 32,500,000 | |
| 31,300,000 | |
| 30,200,000 | |
| 21,900,000 | |
| 14,600,000 | |
| 7,300,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |